247 related articles for article (PubMed ID: 29982174)
1. Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials.
Caplan AL; Teagarden JR; Kearns L; Bateman-House AS; Mitchell E; Arawi T; Upshur R; Singh I; Rozynska J; Cwik V; Gardner SL
J Med Ethics; 2018 Nov; 44(11):761-767. PubMed ID: 29982174
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC).
Caplan A; Bateman-House A; Waldstreicher J; Fedor L; Sonty R; Roccia T; Ukropec J; Jansson R
Ther Innov Regul Sci; 2019 Mar; 53(2):243-248. PubMed ID: 29714573
[TBL] [Abstract][Full Text] [Related]
3. The Ethical Challenges of Compassionate Use.
Caplan AL; Ray A
JAMA; 2016 Mar; 315(10):979-80. PubMed ID: 26868205
[No Abstract] [Full Text] [Related]
4. Dilemmas in the compassionate supply of investigational cancer drugs.
Lewis JR; Lipworth W; Kerridge I; Doran E
Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421
[TBL] [Abstract][Full Text] [Related]
5. Should patients in need be given access to experimental drugs?
Caplan AL; Bateman-House A
Expert Opin Pharmacother; 2015 Jun; 16(9):1275-9. PubMed ID: 26001178
[TBL] [Abstract][Full Text] [Related]
6. Compassionate use of unauthorized drugs: Legal regulations and ethical challenges.
Borysowski J; Górski A
Eur J Intern Med; 2019 Jul; 65():12-16. PubMed ID: 31036436
[TBL] [Abstract][Full Text] [Related]
7. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
Finkelstein PE
AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
[No Abstract] [Full Text] [Related]
8. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
9. Compassionate use programs in Italy: ethical guidelines.
De Panfilis L; Satolli R; Costantini M
BMC Med Ethics; 2018 Mar; 19(1):22. PubMed ID: 29523198
[TBL] [Abstract][Full Text] [Related]
10. Food and Drug Administration responds to pressure for expanded drug access.
Brower V
J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
[No Abstract] [Full Text] [Related]
11. Fairer way to distribute last-ditch drugs gets real-world trial.
Reardon S
Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187
[No Abstract] [Full Text] [Related]
12. [Second Opinion, Compassionate Use, and Clinical Trial].
Sanz Rubiales Á; Fernández González M
Cuad Bioet; 2017; 28(92):127-128. PubMed ID: 28342439
[No Abstract] [Full Text] [Related]
13. Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
Stout J; Smith C; Buckner J; Adjei AA; Wentworth M; Tilburt JC; Master Z
PLoS One; 2021; 16(12):e0261478. PubMed ID: 34919568
[TBL] [Abstract][Full Text] [Related]
14. Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs.
Bunnik EM; Aarts N; van de Vathorst S
Health Policy; 2018 Sep; 122(9):977-983. PubMed ID: 29935731
[TBL] [Abstract][Full Text] [Related]
15. The Practice of Pharmaceutics and the Obligation to Expand Access to Investigational Drugs.
Buckley M; O'neil C
J Med Philos; 2020 Mar; 45(2):193-211. PubMed ID: 31885051
[TBL] [Abstract][Full Text] [Related]
16. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
17. An ethical dilemma. Availability of antiretroviral therapy after clinical trials with HIV infected patients are ended.
Cleaton-Jones PE
BMJ; 1997 Mar; 314(7084):887-8. PubMed ID: 9093104
[No Abstract] [Full Text] [Related]
18. Improving Expanded Access in the United States: The Role of the Institutional Review Board.
Folkers KM; Bateman-House A
Ther Innov Regul Sci; 2018 May; 52(3):285-293. PubMed ID: 29723059
[TBL] [Abstract][Full Text] [Related]
19. Single-Patient Expanded Access Requests: IRB Professionals' Experiences and Perspectives.
Chapman CR; Shearston JA; Folkers KM; Redman BK; Caplan A; Bateman-House A
AJOB Empir Bioeth; 2019; 10(2):88-99. PubMed ID: 30964737
[TBL] [Abstract][Full Text] [Related]
20. Before It's Too Late: Multistakeholder Perspectives on Compassionate Access to Investigational Drugs for Pediatric Patients With Cancer.
Gerasimov E; Donoghue M; Bilenker J; Watt T; Goodman N; Laetsch TW
Am Soc Clin Oncol Educ Book; 2020 May; 40():1-10. PubMed ID: 32412804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
